top of page
it's where dermatology lives

EADV Congress 2023
Live Video Reports
.png)
live at

Derm.City presents thrice-daily reports from key opinion leaders in dermatology live from the EADV Congress 2023 in Berlin.
EADV 2023 Day 1 Morning:
The Pathogenesis of Psoriasis
EADV 2023 Day 1 Afternoon:
Late Breaking HS and Alopecia Developments
EADV 2023 Day 1 Evening:
Late Breakers in Atopic Dermatitis
EADV 2023 Day 2 Morning:
Late Breaking Psoriasis Presentations
EADV 2023 Day 2 Afternoon:
Treating Severe Atopic Dermatitis with Tapinarof 1% Cream
EADV 2023 Day 2 Evening:
Molecular Signature of Chronic Hand Eczema
EADV 2023 Day 3 Morning:
Bullous Diseases
EADV 2023 Day 3 Afternoon:
Efficacy and Safety of Rezpegaldesleukin
EADV 2023 Day 3 Evening:
Abrocitinib for Prurigo Nodularis in Chronic Pruritis
EADV 2023 Day 4 Morning:
Congress Presentations of Interest
EADV 2023 Day 4 Afternoon:
JAK Inhibitors and Inflammatory Skin Disease
EADV 2023 Special Report:
Long-Term Deucravacitinib Treatment for Plaque Psoriasis
bottom of page